THE SCIENCE BEHIND GALLIPRO® FIT
PERFORMANCE PROGRAMME
GALLIPRO® FIT improves productivity in broilers under commercial conditions:
1%
reduced mortality on average1
3pt
average reduction of feed conversion ratio (FCR)2
58g
average bodyweight improvement1
+3.5%
increased European Production Efficiency Factor (EPEF)2
Reduced
condemnations2
Improved
flock uniformity2 associated with predictable and more profitable results3,4
CHALLENGE PROGRAMME
GALLIPRO® FIT maintains a robust gut microbiome during times of challenge:
- Utilising multiple mechanisms, the Bacillus strains in GALLIPRO® FIT can successfully compete against undesirable bacterial species, helping to prevent them colonising the gut and compromising Intestinal Integrity.
COMPETITIVE EFFECTS IN ACTION
GALLIPRO® FIT has been shown to inhibit undesirable bacterial species, including:
- Salmonella5,6
- E. coli7,8
- Campylobacter9
- Clostridium10-12
- Various pathogenic E. cecorum (known to contribute towards osteomyelitis and arthritis in broiler chickens)13
This is due to the unique composition of Bacillus strains, which:
Have superior siderophore activity14 meaning undesirable bacterial species don’t have the essential iron that is needed for survival.
Produce lipopeptides
(surfactins and fengycins) known to be inhibitory to some undesirable bacterial species15
Form a beneficial biofilm
which acts as a physical barrier against undesirable bacterial species16
GET STARTED WITH GALLIPRO® FIT TODAY
TRUSTED EXPERTISE
Over 100 years of probiotic experience and a strong ethos of science-backed and real-world tested product development is why, as leaders in gut health improvement solutions, Elanco Animal Health have chosen to partner with Chr. Hansen to bring the benefits of GALLIPRO® FIT to the poultry industry.
1. Chr. Hansen Laboratories, ’28 trials data’.
2. Chr. Hansen Laboratories, Trial No. 80559.
3. Cosgriff B.(2009), Uniformity equals profitability, WattPoultry.
4. Vasdal G, et al. (2019), Associations between carcass weight uniformity and production measures on farm and at slaughter in commercial broiler flocks, Poultry Science.
5. Chr. Hansen Laboratories, Trial No. M 1076.
6. Khan S and Chousalkar KK. (2020) Salmonella Typhimurium infection disrupts but continuous feeding of Bacillus based probiotic restores gut microbiota in infected hens. Journal of Animal Science and Biotechnology.
7. Skjoet-Rasmussen L, et al. (2018) Inhibitory activity of a novel triple-strain Bacillus probiotic (GALLIPRO® FIT) towards Escherichia coli in a feed matrix.
8. Chr. Hansen Laboratories, Trial No. 80677 (in vivo).
9. Chr. Hansen Laboratories, peacock project, 2020.
10. Chr. Hansen Laboratories, Trial No. 80515.
11. Chr. Hansen Laboratories, Trial No. 80450 (in vivo).
12. Chr. Hansen Laboratories, Trial No. 80449.
13. Meuter, et al. (2023) GALLIPRO® FIT reduces growth of pathogenic Enterococcus cecorum isolated from commercial broilers. Chr. Hansen Innovation Laboratories.
14. Bostvironnois, et al. (2023) A triple strain probiotic demonstrates high siderophore activity: a new step towards the understanding of pathogen inhibition in poultry. Poster - International Poultry Scientific Forum, Atlanta I 23-24 January.
15. Chr. Hansen Laboratories - Peacock Project, 2020; ‘Lipopeptide production’ ppt.
16. Konieczka, et al. (2018) Effects of pea extrusion and enzyme and probiotic supplementation on performance, microbiota activity and biofilm formation in the broiler gastrointestinal tract. British Poultry Science, 59:6.
